Stryker price target lowered, added to ‘Tactical Outperform’ list at Evercore

Evercore ISI lowered the firm’s price target on Stryker (SYK) to $410 from $418 and keeps an Outperform rating on the shares, which were added to the firm’s “Tactical Outperform” list. Q3 results should beat expectations, driven by strong Hips & Knees, while Medical should also be strong, the analyst tells investors in a preview.